PofoliaShared via Pofolia

BMJ· 2016Q1· Review

Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies

Emily Bartsch, Karyn E. Medcalf, Alison L. Park, Joel G. Ray

Short summary

A meta-analysis of 92 cohort studies (25M+ pregnancies) identified key early pregnancy risk factors for pre-eclampsia, with antiphospholipid antibody syndrome (17.3% rate) and prior pre-eclampsia (8.4x RR) being the highest risk.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Antiphospholipid antibody syndrome had the highest pooled rate of pre-eclampsia (17.3%).
  • Prior pre-eclampsia showed the greatest pooled relative risk (8.4).
  • Chronic hypertension was the second highest risk factor for both rate (16.0%) and relative risk (5.1).
  • Other significant factors included pregestational diabetes, BMI >30, and assisted reproductive technology use.

AI-generated from the title and abstract; the full text is not read.

Abstract

OBJECTIVE: To develop a practical evidence based list of clinical risk factors that can be assessed by a clinician at ≤ 16 weeks' gestation to estimate a woman's risk of pre-eclampsia. DESIGN: Systematic review and meta-analysis of cohort studies. DATA SOURCES: PubMed and Embase databases, 2000-15. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Cohort studies with ≥ 1000 participants that evaluated the risk of pre-eclampsia in relation to a common and generally accepted clinical risk factor assessed at ≤ 16 weeks' gestation. DATA EXTRACTION: Two independent reviewers extracted data from included studies. A pooled event rate and pooled relative risk for pre-eclampsia were calculated for each of 14 risk factors. RESULTS: There were 25,356,688 pregnancies among 92 studies. The pooled relative risk for each risk factor significantly exceeded 1.0, except for prior intrauterine growth restriction. Women with antiphospholipid antibody syndrome had the highest pooled rate of pre-eclampsia (17.3%, 95% confidence interval 6.8% to 31.4%). Those with prior pre-eclampsia had the greatest pooled relative risk (8.4, 7.1 to 9.9). Chronic hypertension ranked second, both in terms of its pooled rate (16.0%, 12.6% to 19.7%) and pooled relative risk (5.1, 4.0 to 6.5) of pre-eclampsia. Pregestational diabetes (pooled rate 11.0%, 8.4% to 13.8%; pooled relative risk 3.7, 3.1 to 4.3), prepregnancy body mass index (BMI) >30 (7.1%, 6.1% to 8.2%; 2.8, 2.6 to 3.1), and use of assisted reproductive technology (6.2%, 4.7% to 7.9%; 1.8, 1.6 to 2.1) were other prominent risk factors. CONCLUSIONS: There are several practical clinical risk factors that, either alone or in combination, might identify women in early pregnancy who are at "high risk" of pre-eclampsia. These data can inform the generation of a clinical prediction model for pre-eclampsia and the use of aspirin prophylaxis in pregnancy.

The authors' abstract, as published at the source. BMJ, 2016 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Obstetrics and Gynecology

Obstetrics and GynecologyMedicine